Core Viewpoint - The announcement highlights the confidence of the company's executive director and chairman, Pan Honghui, in the overall development and potential growth of the company, as evidenced by his recent share purchase [1] Group 1: Share Purchase Details - Pan Honghui purchased a total of 100,000 ordinary shares of the company at an average price of approximately HKD 6.83 per share, amounting to a total cost of about HKD 683,000 [1] - Following this purchase, Pan holds a total of 17,627,696 shares, representing 16.44% of the company's total issued share capital as of the announcement date [1] Group 2: Future Intentions - Pan Honghui has indicated that he may consider further increasing his stake in the company at an appropriate time, in compliance with applicable laws and regulations [1]
圣诺医药-B(02257.HK)获执行董事兼主席潘洪辉增持10万股公司普通股